Organon Price to Book Ratio 2019-2025 | OGN
Historical price to book ratio values for Organon (OGN) over the last 10 years. The current price to book ratio for Organon as of May 22, 2025 is 4.04.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Organon Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-05-22 | 8.69 | 4.14 | |
2025-03-31 | 14.86 | $2.10 | 7.07 |
2024-12-31 | 14.62 | $1.83 | 7.98 |
2024-09-30 | 18.41 | $1.91 | 9.62 |
2024-06-30 | 19.65 | $0.56 | 35.13 |
2024-03-31 | 17.60 | $0.19 | 93.83 |
2023-12-31 | 13.30 | $-0.27 | -48.57 |
2023-09-30 | 15.62 | $-2.30 | -6.78 |
2023-06-30 | 18.49 | $-2.17 | -8.51 |
2023-03-31 | 20.62 | $-2.90 | -7.12 |
2022-12-31 | 24.23 | $-3.51 | -6.91 |
2022-09-30 | 20.06 | $-4.19 | -4.79 |
2022-06-30 | 28.68 | $-4.47 | -6.42 |
2022-03-31 | 29.44 | $-4.93 | -5.97 |
2021-12-31 | 25.47 | $-5.95 | -4.28 |
2021-09-30 | 27.18 | $-6.38 | -4.26 |
2021-06-30 | 24.88 | $-7.63 | -3.26 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $2.191B | $6.403B |
Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $133.694B | 25.08 |
Elevance Health (ELV) | United States | $90.401B | 11.66 |
CVS Health (CVS) | United States | $78.570B | 9.77 |
Cencora (COR) | United States | $56.472B | 19.65 |
DiDi Global (DIDIY) | China | $22.450B | 34.07 |
Natera (NTRA) | United States | $20.631B | 0.00 |
BioMerieux (BMXMF) | France | $15.355B | 0.00 |
Solventum (SOLV) | United States | $12.588B | 13.33 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.514B | 0.00 |
CochLear (CHEOY) | Australia | $11.382B | 0.00 |
Revvity (RVTY) | United States | $10.588B | 18.22 |
ICON (ICLR) | Ireland | $10.225B | 9.51 |
Viatris (VTRS) | United States | $9.953B | 3.42 |
Doximity (DOCS) | United States | $9.475B | 44.13 |
Avantor (AVTR) | United States | $8.552B | 12.43 |
HealthEquity (HQY) | United States | $8.545B | 42.04 |
Medpace Holdings (MEDP) | United States | $8.501B | 22.58 |
Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
Charles River Laboratories (CRL) | United States | $6.630B | 12.99 |
Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
BrightSpring Health Services (BTSG) | United States | $4.137B | 38.29 |
Bausch + Lomb (BLCO) | Canada | $3.955B | 23.31 |
Sotera Health (SHC) | United States | $3.503B | 19.90 |
Alignment Healthcare (ALHC) | United States | $3.033B | 0.00 |
Surgery Partners (SGRY) | United States | $2.905B | 37.78 |
Concentras Parent (CON) | United States | $2.803B | 16.20 |
Ardent Health Partners (ARDT) | United States | $2.137B | 9.11 |
GeneDx Holdings (WGS) | United States | $1.934B | 74.48 |
Premier (PINC) | United States | $1.899B | 14.41 |
Progyny (PGNY) | United States | $1.816B | 39.98 |
PACS (PACS) | United States | $1.506B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.354B | 27.07 |
Pediatrix Medical (MD) | United States | $1.303B | 9.91 |
Teladoc Health (TDOC) | United States | $1.223B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.037B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
Agilon Health (AGL) | United States | $0.973B | 0.00 |
CareDx (CDNA) | United States | $0.949B | 14.83 |
Nutex Health (NUTX) | United States | $0.941B | 14.21 |
AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
Embecta (EMBC) | United States | $0.722B | 4.86 |
InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
Enhabit (EHAB) | United States | $0.528B | 43.46 |
Auna S.A (AUNA) | Luxembourg | $0.506B | 11.40 |
LifeMD (LFMD) | United States | $0.489B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.403B | 0.00 |
SBC Medicals (SBC) | United States | $0.360B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.204B | 0.00 |
Oncology Institute (TOI) | United States | $0.202B | 0.00 |
Beauty Health (SKIN) | United States | $0.195B | 0.00 |
KindlyMD (KDLY) | United States | $0.137B | 0.00 |
DocGo (DCGO) | United States | $0.131B | 21.33 |
So-Young (SY) | China | $0.089B | 0.00 |
OncoCyte (OCX) | United States | $0.088B | 0.00 |
Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
NeueHealth (NEUE) | United States | $0.060B | 0.00 |
Biodesix (BDSX) | United States | $0.058B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
ModivCare (MODV) | United States | $0.013B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |